Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation

Author： Shewale Anand   Johnson Jill   Li Chenghui   Nelsen David   Martin Bradley  

Publisher： MDPI

E-ISSN： 2227-9032|3|1|130-145

ISSN： 2227-9032

Source： Healthcare, Vol.3, Iss.1, 2015-03, pp. : 130-145

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

By Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 384-397

MDPI

Access to resources Recommend Favorite

ABCB1 and SLCO1B3 Gene Polymorphisms and Their Impact on Digoxin Pharmacokinetics in Atrial Fibrillation Patients among the Tunisian Population

By  

Pharmacology, Vol. 99, Iss. 5-6, 2017-02 ,pp. : 250-258

Karger

Access to resources Recommend Favorite

A Survey of Long‐Term Antiarrhythmic Therapy in Elderly Patients with Atrial Fibrillation

By  

The Australian Journal of Hospital Pharmacy, Vol. 31, Iss. 2, 2001-06 ,pp. : 93-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developing a Complex Educational–Behavioural Intervention: The TREAT Intervention for Patients with Atrial Fibrillation

By Clarkesmith Danielle E.   Pattison Helen M.   Borg Xuereb Christian   Lane Deirdre A.  

Healthcare, Vol. 4, Iss. 1, 2016-01 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Update on the Non-Pharmacological Management of Stroke Prevention in Patients with Atrial Fibrillation

By Tolat Aneesh   Lippman Neal  

Journal of Clinical Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 32-32

MDPI

Access to resources Recommend Favorite